Masamitsu Yanada

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed <i>BCR</i>-<i>ABL</i>–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura et al. · Journal of Clinical Oncology · 2005 · 454 citations · Full text

Medicine, Hematology, Oncology +15

Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome

Masamitsu Yanada, Tadashi Matsushita, Norio Asou et al. · European Journal Of Haematology · 2006 · 129 citations · Full text

Medicine, Hematology, Oncology +16

Syndecan-4 Deficiency Leads to High Mortality of Lipopolysaccharide-injected Mice

Kazuhiro Ishiguro, Kenji Kadomatsu, Tetsuhito Kojima et al. · Journal of Biological Chemistry · 2001 · 126 citations · Full text

Life Sciences, Immunology, Physiology +16

Prospective monitoring of <i>BCR‐ABL1</i> transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib‐combined chemotherapy

Masamitsu Yanada, Isamu Sugiura, Jin Takeuchi et al. · British Journal of Haematology · 2008 · 101 citations · Full text

Medicine, Hematology, Oncology +17

Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia

Masamitsu Yanada, Motohiro Tsuzuki, Hiroyuki Fujita et al. · Blood · 2013 · 78 citations

Medicine, Hematology, Oncology +15